Encorafenib in Combination With Cetuximab After Systemic Therapy in Patients With BRAF(V600E) Mutant Metastatic Colorectal Cancer: German Health Technology Assessment-Driven Analyses From the BEACON CRC Study

Erstveröffentlichung
2022
Authors
Stintzing, Sebastian
Seufferlein, Thomas
Rose, Christian
Reichenbach, Frank
Lüftner, Diana
Wissenschaftlicher Artikel


Published in
Clinical Colorectal Cancer ; 21 (2022), 3. - S. 244-251. - ISSN 1533-0028. - eISSN 1938-0674
Link to publication
https://dx.doi.org/10.1016/j.clcc.2022.04.002
Institutions
UKU. Klinik für Innere Medizin I
Subject headings
[Free subject headings]: BRAF(V600E)-mutation | Irinotecan | Overall survival | Progression-free survival | Time-to-event | 1ST-LINE TREATMENT | BRAF MUTATION | VEMURAFENIB | SURVIVAL | FLUOROURACIL | LEUCOVORIN | INHIBITION
[DDC subject group]: DDC 610 / Medicine & health
Metadata
Show full item record